{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:49:13Z","timestamp":1792169353890,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFE0103000"],"award-info":[{"award-number":["2018YFE0103000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.amjcard.2023.07.175","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T13:05:00Z","timestamp":1704805500000},"page":"86-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Revascularization for Patients With Heart Failure With Preserved Ejection Fraction and Coronary Artery Disease"],"prefix":"10.1016","volume":"213","author":[{"given":"Mingqiang","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueting","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juying","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingmin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2023.07.175_bib0001","first-page":"897","article-title":"Heart failure with preserved ejection fraction","volume":"376","author":"Redfield","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0002","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/j.jvca.2020.07.016","article-title":"Heart failure with preserved ejection fraction: a comprehensive review and update of diagnosis, pathophysiology, treatment, and perioperative implications","volume":"35","author":"Pagel","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0003","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/jama.300.4.431","article-title":"Heart failure with preserved ejection fraction: treat now by treating comorbidities","volume":"300","author":"Shah","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0004","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0005","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0006","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.111.080770","article-title":"Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes","volume":"126","author":"Steinberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0007","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0008","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1253\/circj.CJ-18-0073","article-title":"Clinical characteristics, management, and outcomes of Japanese patients hospitalized for heart failure with preserved ejection fraction- A report from the Japanese heart failure syndrome with preserved ejection fraction (JASPER) registry","volume":"82","author":"Nagai","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0009","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11936-009-0060-2","article-title":"Evolving approaches to the management of heart failure with preserved ejection fraction in patients with coronary artery disease","volume":"12","author":"Shah","year":"2010","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0010","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.jacc.2014.03.034","article-title":"Implications of coronary artery disease in heart failure with preserved ejection fraction","volume":"63","author":"Hwang","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0011","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1253\/circj.CJ-19-0963","article-title":"Differential prognostic impact of atrial fibrillation in hospitalized heart failure patients with preserved ejection fraction according to coronary artery disease status- report from the Japanese nationwide multicenter registry","volume":"84","author":"Temma","year":"2020","journal-title":"Circ J"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0012","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0735-1097(91)90589-2","article-title":"Congestive heart failure symptoms in patients with preserved left ventricular systolic function: analysis of the CASS registry","volume":"18","author":"Judge","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0013","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0002-9149(00)01107-3","article-title":"Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function","volume":"86","author":"O'Connor","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0014","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCHEARTFAILURE.111.966366","article-title":"Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction","volume":"5","author":"Dunlay","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0015","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0016","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.010080","article-title":"Efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction according to age: the DELIVER trial","volume":"15","author":"Peikert","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0017","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0018","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0019","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0020","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0021","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.16598","article-title":"Association of beta-blocker use with heart failure hospitalizations and cardiovascular disease mortality among patients with heart failure with a preserved ejection fraction: a secondary analysis of the TOPCAT trial","volume":"2","author":"Silverman","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0022","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5603\/CJ.2020.0023","article-title":"Coding proposal on phenotyping heart failure with preserved ejection fraction: A practical tool for facilitating etiology-oriented therapy","volume":"27","author":"Ge","year":"2020","journal-title":"Cardiol J"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0023","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.amjcard.2020.11.034","article-title":"Role of ischemic Heart Disease in major adverse renal and cardiac events among individuals with heart failure with preserved ejection fraction (from the TOPCAT trial)","volume":"142","author":"Rahimi","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0024","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ehf2.13070","article-title":"Predominant subtype of heart failure after acute myocardial infarction is heart failure with non-reduced ejection fraction","volume":"8","author":"Kamon","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0025","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0026","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0027","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","article-title":"Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment","volume":"32","author":"Borlaug","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.822248","article-title":"Initial invasive or conservative strategy in heart failure with preserved ejection fraction and coronary artery disease","volume":"9","author":"Gu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.amjcard.2023.07.175_bib0029","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/CIRCULATIONAHA.119.042569","article-title":"Biomarker correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction","volume":"140","author":"Tromp","year":"2019","journal-title":"Circulation"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291492300752X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291492300752X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:03:40Z","timestamp":1792166620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000291492300752X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":29,"alternative-id":["S000291492300752X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.07.175","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revascularization for Patients With Heart Failure With Preserved Ejection Fraction and Coronary Artery Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.07.175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}